We present a mass spectrometry (MS)-based nucleoside-specific mass-tagging method to validate genomic DNA sequences containing ambiguities not resolved by gel electrophoresis. Selected types of 13 C/ 15 N-labeled dNTPs are used in PCR amplification of target regions followed by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF)-MS analysis. From the mass difference between the PCR products generated with unlabeled nucleosides and products containing 13 C/ 15 N-labeled nucleosides, we determined the base composition of the genomic regions of interest. Two approaches were used to verify the target regions: The first approach used nucleosides partially enriched with stable isotopes to identify a single uncalled base in a gel electrophoresis-sequenced region. The second approach used mass tags with 100% heavy nucleosides to examine a GC-rich region of a polycytidine string with an unknown number of cytidines. By use of selected 13 C/ 15 N-labeled dNTPs (dCTPs) in PCR amplification of the target region in tandem with MALDI-TOF-MS, we determined precisely that this string contains 11 cytidines. Both approaches show the ability of our MS-based mass-tagging strategy to solve critical questions of sequence identities that might be essential in determining the proper reading frames of the targeted regions.
N-labeled dNTPs are used in PCR amplification of target regions followed by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF)-MS analysis. From the mass difference between the PCR products generated with unlabeled nucleosides and products containing 13 C/ 15 N-labeled nucleosides, we determined the base composition of the genomic regions of interest. Two approaches were used to verify the target regions: The first approach used nucleosides partially enriched with stable isotopes to identify a single uncalled base in a gel electrophoresis-sequenced region. The second approach used mass tags with 100% heavy nucleosides to examine a GC-rich region of a polycytidine string with an unknown number of cytidines. By use of selected 13 C/ 15 N-labeled dNTPs (dCTPs) in PCR amplification of the target region in tandem with MALDI-TOF-MS, we determined precisely that this string contains 11 cytidines. Both approaches show the ability of our MS-based mass-tagging strategy to solve critical questions of sequence identities that might be essential in determining the proper reading frames of the targeted regions.
The major challenge in biology is to understand the function of living cells at the molecular level. To address this challenge, a major effort is now underway to sequence the genomes of a range of eukaryotic and prokaryotic organisms. Through these efforts, the draft sequence of the human genome has been completed very recently (Genome Consortium 2001) . This draft sequence provides the foundation for the identification of gene sequences and the ultimate understanding of the functions of their protein products in both human diversity and disease development (Godovac-Zimmermann and Brown 2001) . To accomplish these objectives, an accurate genome sequence is essential for the subsequent studies of gene functions; however, the current draft of the human genome sequence contains many short regions that are still unresolved mainly because of difficulties in sequencing these regions or artifacts caused by gel electrophoresis. These regions are found throughout the genome and are either primarily GC rich or consist of long repeats (Genome Consortium 2001). They form "hot spots" in the genome that are difficult to sequence and often result in inconsistent data on resequencing. It is essential that these inconsistencies be resolved accurately to prevent problems in interpreting the expression of genes in these regions.
In the past decade, mass spectrometry (MS) has become an essential tool in both DNA and protein analyses, as well as the key technology in the emerging fields of proteomics and functional genomics (Godovac-Zimmermann and Brown 2001) . Developed in the late 1980s, matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF)-MS (Karas and Hillenkamp 1988) provided fast and accurate measurements of the molecular masses of short DNA sequences (Murray 1999) . The strength of MS lies in the fact that it uses an intrinsic property of molecules-their masses. In addition, the ability to measure directly the mass-to-charge (m/z) ratio of biomolecules with high accuracy made a wide range of bioanalytical applications available to MS analysis (Blackstock and Weir 1999; Pandey and Mann 2000; Yates 2000) . Because of its speed, accuracy, and sensitivity, MALDI-TOF-MS has become a powerful tool for the efficient sequencing of short DNA fragments as well as genotyping of single nucleoside polymorphisms (SNPs) Smirnov 1997a, 1997b; Fei et al. 1998; Laken et al. 1998; Ross et al. 1998; Guo 1999; Li et al. 1999; Fei and Smith 2000; Griffin and Smith 2000; Sun et al. 2000; Abdi et al. 2001) .
Recently, we have developed a novel MS-based approach that uses stable isotope-labeled nucleosides (99% 13 C/ 15 Nlabeled) to determine the base composition of PCR products. By measuring the mass shifts between labeled and unlabeled PCR products amplified from target regions, we were able to determine the number of each type of the labeled nucleosides in both the (+)-and (‫-)מ‬strands of the DNA sequences of interest (Chen et al. 1999) . Further, we extended this approach to genotype SNPs. The incorporation of 50% 13C/ 15N-labeled nucleosides (1 : 1 molar ratio of labeled and unlabeled nucleosides) in wild-type, mutant, and heterozygous PCR products from genomic DNA provided unique mass-split patterns in MS spectra that allowed the determination of substituted patterns of SNPs (Abdi et al. 2001) .
MS-based DNA sequencing and SNP genotyping approaches have emerging roles in the next generation of genomic studies. Here we show our mass-tagging strategy that combines the incorporation of 13 C/ 15 N-labeled nucleosides with MALDI-TOF-MS analysis to validate DNA sequence data obtained by gel electrophoresis-based sequencing methods. In this study we determined the identity of an uncalled base in chromosome 16 and a GC-rich sequence located in chromosome 19 of the human genome. The uncalled base was identified using 50% 13 C/ 15 N-labeled nucleosides as precursors for PCR amplification. For the GC-rich region containing multiple cytidines in a string that gave inconsistent data by gel electrophoresis-based sequencing, the precise number of cytidines was determined successfully using mass-tagging MS.
RESULTS
Two different regions in chromosomes 16 and 19 of the human genome sequence were examined for MS validation because their sequences could not be determined clearly by gel electrophoresis-based DNA sequencing. First, a GC-rich region of chromosome 19 was sequenced repeatedly by gel electrophoresis. Each attempt indicated the presence of a multiple cytidine string with lengths varying from 10 to 12 cytidines ( Fig. 1) . This inconsistency revealed a deficiency in sequencing accuracy using mobility-based gel electrophoresis methods. To resolve this ambiguity, the target region was first amplified by PCR using 13 C/ 15 N-labeled dCTPs mixed with equimolar amounts of the other three unlabeled dNTPs to generate nucleoside-specific mass-tagged PCR products. By measuring the mass difference between the unlabeled (UL) and the 13 C/ 15 N-labeled (L) PCR products, the target region was determined to contain 11 cytidines. The MALDI-TOF-MS spectrum of the unlabeled PCR product shows peaks with m/z values of 9056.8 for its (+)-strand and 9958.6 for its (‫-)מ‬strand ( Fig. 2A) . The 99% 13 C/ 15 N-dCTP-labeled PCR product gave peaks with m/z values of 9189.5 for the (+)-strand and 9958.5 for the (‫-)מ‬strand (Fig. 2B ). The mass shift between the labeled and the unlabeled (+)-strands is 132.7 Da. This mass shift is equivalent to the 13 C/ 15 N labeling of 11 cytidines as the mass of each 13 C/ 15 N-labeled cytidine is expected to shift by 12.1 Da. The (‫-)מ‬strand of both labeled and unlabeled products remained unchanged with a minimal mass shift of <1 Da. Figure 2C shows the MALDI-TOF-MS spectrum of a mixture of equal amounts of both unlabeled and 13 C/ 15 N-dCTPlabeled PCR products of the same region. This allows the direct determination of the relative mass shift of the labeled species compared with the unlabeled species and is independent of mass calibrants. The mass shift between the labeled and the unlabeled (+)-strands when both populations are present in the sample is 134.8 Da, which is also consistent with 11 13 C/ 15 N-labeled cytidines in the PCR product. The molecular mass of the (‫-)מ‬strands of the mixture showed no detectable shift as expected for a string of 11 guanosines.
To verify the above findings, a partial digestion of the PCR products of the same region using Exonuclease III was performed to determine the exact sequence of this polycytidine string. MALDI-TOF-MS analysis of the digests clearly indicated the presence of 11 consecutive cytidines in the amplified region as shown in Figure 3 . The digestion also identified 4 or 5 flanking nucleosides from both the 3Ј and the 5Ј ends (Fig. 3) . Exonuclease III is known to cut from the 3Ј end of double-stranded DNA, but because of the interference of the matrix signals, the first 4 nucleosides were not clearly assigned. Although this experiment is very informative in determining the exact sequence of the amplified region, it is time-and sample-consuming. It requires ∼5 µg of purified PCR DNA samples with two additional steps of restriction digestion and a lengthy membrane dialysis. This makes the whole analytical process less adaptable for high throughput. Another difficult region found in human chromosome 16 contained a single base that could not be assigned correctly by gel electrophoresis-based sequencing. The failure to identify this nucleoside represents major problems to (1) precise genotyping of an SNP, (2) the identification of an insertion or a deletion, and (3) the determination of the correct genetic code of the targeted sequence. For validation of the identity of the uncalled base, a 9-bp target region containing the uncalled base was amplified using primers containing Hph I restriction sites that allow for the generation of a 10-bp fragment on digestion as previously described (Abdi et al. 2001) . Hph I has the recognition sequence of 5Ј. . .GGTGA (N 8 ). . .3Ј and 3Ј. . .CCACT (N 7 ). . .5Ј, which dictates the restriction cleavage at the 8th base from the 5Ј end and the 7th from the 3Ј end resulting in a protruding base at the 3Ј end of each strand of the target region. The 3Ј end of each The MALDI-TOF-MS analysis of the 10-bp fragment containing the uncalled nucleoside gave m/z ratios of 3120.7 and 3068.2 for the (+)-and (‫-)מ‬strands, respectively (Fig. 5A) . To identify the uncalled nucleoside, the target region was amplified using 50% 13 C/ 15 N-labeled nucleosides of each of dATPs, dCTPs, dGTPs, or dTTPs in an equimolar mixture with the other three unlabeled dNTPs. MALDI analysis of the Hph I digest of 50% 13 C/ 15 N-labeled-dATP PCR product gave a set of four peaks with m/z ratios of 3069.2, 3082.3, 3098.2, and 3112.1 for the (‫-)מ‬strand. The (+)-strand was represented with three peaks with m/z values of 3120.6, 3135.8, and 3151.0 (Fig. 5B) . These peaks were separated by ∼15 Da, indicating the presence of three adenosines in the (‫-)מ‬strand and two adenosines in the (+)-strand because labeled adenosines are 15 Da heavier than the unlabeled ones. Knowing that the called nucleoside composition of the 10-bp (+)-strand is 1 A, 1 C, 4 Ts, and 3 Gs (Fig. 4) , it follows that the uncalled nucleoside is an adenosine. Similarly, the MALDI-TOF spectrum of the 50% 13 C/ 15 N-labeled-dTTP PCR product indicated that the (‫-)מ‬strand showed three peaks with m/z ratios of 3068.4, 3079.9, and 3091.7, and the (+)-strand gave four peaks with m/z ratios of 3118.5, 3132.8, 3144.5, and 3156.9 (Fig. 5C ). For both strands, the peaks were separated by ∼12 Da, confirming the presence of two and three isotopically labeled thymidines, respectively.
The MALDI-TOF-MS spectrum of the 50% 13 C/ 15 Nlabeled-dCTP PCR product contained three peaks with m/z ratios of 3070.3, 3081.8, 3093.3, and 3105.7 for the ‫-)מ(‬ strand and two peaks with m/z ratios of 3121.4 and 3133.6 for the (+)-strand (Fig. 5D ). These four peaks of the (‫-)מ‬strand were separated by ∼12 Da, indicating the presence of three cytidines in the (‫-)מ‬strand. Similarly, the two peaks of the (+)-strand indicated the presence of a single cytidine. MS analysis of the 50% 13 C/ 15 N-labeled-dGTP PCR product gave two peaks for the (‫-)מ‬strands with m/z ratios of 3067.0 and 3081.8. The (+)-strand showed four peaks with an m/z ratio of 3120.4, 3135.1, 3150.6, and 3164.0 (Fig.  5E ). These two sets of peaks confirmed the presence of a single guanosine in the (‫-)מ‬strand and three guanosines in the (+)-strand.
DISCUSSION
The draft sequence of the human genome has generated considerable scientific interest. It is the first vertebrate and the largest eukaryotic genome to be sequenced. Approximately 94% of the human genome has been sequenced, and much work remains to finish the sequence. Many short regions remain unresolved, and they vary from single uncalled nucleosides to long polynucleotide repeats. To identify these nucleoside sequences, we developed a more accurate and efficient strategy coupling nucleosidespecific mass tagging and MALDI-TOF-MS.
The exact number of the particular type of nucleosides is determined by a one-step measurement of the mass shift induced by the incorporation of labeled nucleosides. This greatly simplifies sample preparation for sequence validation without the need to resequence the entire target region. Two previously unresolved regions found in chromosomes 16 and 19 of the human genome were analyzed. The first region contained a polycytidine string, and the second contained a single uncalled base. MALDI-TOF-MS measurement of the mass shift between the unlabeled and 100% labeled PCR products verified that the multiple cytidine string contains 11 cytidines. Knowing the mass tag for each type of nucleoside, the mass shifts of the PCR-amplified products give the exact number of nucleosides present in the amplified region. Because labeled cytidines were used, the mass shift in the (+)-strand of the amplified region can come only from cytidines present in this region. In contrast, the ‫-)מ(‬ strand of the PCR amplified region did not show any mass shift. The amplified region of this strand contains a string of guanosines, and its mass therefore is not expected to shift on labeling with heavy cytidine nucleosides. The minor shift of 0.1 Da noticed in the (‫-)מ‬strand in Figure 2 , A and B, can be attributed to experimental error. To accurately determine the mass shift between the labeled and unlabeled species, we included both populations in the same measurement. This allowed an accurate mass shift to be determined by comparing the mass change of the labeled with the unlabeled species. The (‫-)מ‬strands of both the labeled and unlabeled species overlapped and did not show any mass shift.
The exonuclease used here cuts the double-stranded PCR product one base at a time from the 3Ј end. An incomplete digest of the amplified product generated a DNA ladder that was detectable by MALDI-TOF-MS (Fig. 3) . This exonuclease digestion, however, is not required for our determination of the sequence composition, but it serves to confirm the exact sequence. This step is both time-and sample-consuming and requires multiple PCR products, an extra enzymatic digestion, and further steps of dialysis that reduce its throughput capabilities.
Figure 3
Negative-ion MALDI-TOF-MS spectrum of a PCR product after exonuclease digestion. This spectrum clearly shows the presence of 11 consecutive cytidines flanked by the known sequence at the 3Ј and 5Ј ends. The doubly charged ion of the remaining undigested PCR product gave an approximate mass-to-charge (m/z) value of 4581 between the sixth and the seventh sequential cytidines. The secondary series of peaks visible between 2000 and 4500 amu are mainly caused by partial digestion of the complementary strand of the PCR product from the 3Ј end.
The use of stable isotopes not only can resolve strings of multiple nucleosides but also can determine the identity of either a single nucleoside or strings of different nucleosides of unresolved sequences. For example, if unresolved regions contain one, two, three, or even four different types of nucleosides, then the use of 50% 13 C/ 15 N-labeled dNTPs provides an internal marker to determine the exact number of each nucleoside present in that region. In our example, knowing the constituents of the sequences of the flanking regions of the uncalled base proved to be essential in genotyping the base in question. Fifty percent 13 C/ 15 Nlabeled dATPs with unlabeled dCTPs, dGTPs, and dTTPs unequivocally proved that the base in question is an adenosine. The presence of three peaks in the MALDI-TOF spectrum of the (+)-strand of the 50% 13 C/ 15 N-labeled dATPs further confirmed the presence of two adenosines in the amplified region, and knowing that there is only one adenosine in the flanking regions confirms the identity of the uncalled base to be an adenosine.
In addition, what is striking about our method is not only its accuracy and efficiency of data production but also its cost-effectiveness. In our PCR-labeling experiments, only one type of 13 C/ 15 Nlabeled dNTPs is mixed with the other three types of dNTPs. Meanwhile, only nanomole quantities of labeled nucleosides are required for the PCR amplification of target regions because of the sensitivity of MS analysis. The cost for each type of the 13 C/ 15 N-labeled dNTPs is ∼$60 per 1 mg (3 µmole), which is sufficient for >1000 PCR-labeling reactions, that is, ∼16¢ for each MS measurement.
Further, the characteristic mass-split patterns induced by the partially 13 C/ 15 N-enriched dNTPs not only indicated the number of labeled precursors but also detected the base substitution in each mass peak and hence provided an efficient method for single-base detection. This leads us to believe that this MS-based DNA validation method will probably play an important role in the next phase of genomic studies by providing a simple and efficient high-throughput method to resolve the many ambiguities contained in the genome sequence.
METHODS

Chemicals and Enzymes
Unlabeled dNTPs were obtained from Promega. Stable isotope-enriched nucleoside precursors, >99% 13 C and 15 N ( 13 C/ 15 N)-labeled dNTPs, were purchased from Martek Biosciences Corporation. We have separated four types of 13 C/ 15 N-labeled nucleosides by reverse-phase high-performance liquid chromatography (HPLC) (Vydac C18 reverse phase 218TP54 HPLC column). Taq DNA polymerase was purchased from Qiagen. Float dialysis membranes (VSWP 02500 with 0.025-µm pore size) were purchased from Millipore. 3-Hydroxypicolinic acid (3-HPA) was obtained from Aldrich Chemical Company. Di- alysis tubing with 3500 Da molecular weight cutoff was obtained from Pierce. Exonuclease III and Hph I restriction enzymes were purchased from New England Biolabs.
Genomic DNA and Primers
Genomic DNA samples for chromosomes 16 (CIT 2285-C9) and chromosome 19 (Cosmid R28832) were obtained from the Joint Genome Institute at Los Alamos National Laboratory (LANL). All oligonucleoside primers were synthesized and purified using DNA synthesizer at the LANL Center for Human Genome Studies.
For amplification of the target region of chromosome 16 containing the uncalled single nucleoside, we have designed a set of primers to generate Hph I mid-digests containing the uncalled sequence. The primers are 5Ј-ATCGAGCTGGTGATC AATGTA-3Ј (forward) and 5Ј-TAGTTCCCGGTGATGTGATTA-3Ј (reverse). The Hph I recognition sites are underlined. For the amplification of the unresolved region of chromosome 19, a set of primers flanking the target sequence was designed. The primers used were 5Ј-CCATCTCACC-3Ј (forward) and 5Ј-GAGGGAGATC-3Ј (reverse).
PCR Labeling of Target Regions
PCR amplifications were performed on a 50-µL scale and each reaction tube contained 5 µL 10 X PCR reaction buffer, 50 ng DNA template, 100 ng DNA primers, 0.25 µL (5 U/µL) Taq polymerase, 5 µL (25 mM/µL) Mg Cl 2, and 1.2 µL (10 mM) of dNTPs (N = G, A, T, or C). Genomic DNA templates were treated with an initial denaturation cycle at 94°C for 2 min. The amplification was performed at 94°C for 25 cycles of 30 sec for denaturation, at 50°C for 30 sec for annealing, and at 72°C for 30 sec for extension. A final extension step at 72°C was performed for 1 min. To generate nucleoside-specific mass-tagged PCR products, the 13 C/ 15 N-labeled dCTP were mixed with the other three unlabeled dNTPs. The 50% labeled dNTPs were generated by mixing 99% labeled nucleosides and unlabeled ones in a 1 : 1 ratio. PCR amplifications using 50% labeled nucleosides were performed as described earlier. Hph I digestion of the amplified DNA and the purification of the 10-bp fragment were achieved as described by Abdi et al. 2001 .
Sample Preparation and Exonuclease Digestion
PCR products amplified from chromosome 19 samples were purified using phenol : chloroform : isoamylalcohol (25 : 24 : 1) followed by ethanol precipitation, then washed with 70% ethanol and dried in a Savant SpeedVac DNA concentrator. Samples were resuspended in dH 2 O and dialyzed overnight against ddH 2 O using high-performance dialysis tubing with a molecular weight cutoff mass of 3500 Da. Ten microliters of purified DNA product (0.5 µg/µL) were mixed with 0.1 µL (100 U/µL) of Exonuclease III and 2 µL of 10 X Exonuclease III buffer (66 mM Tris-HCl at pH 8.0, 0.66 mM MgCl 2 ). Reaction volume was brought to 20 µL with dH 2 O and then incubated at 37°C for 5 min. Reaction was stopped by placing samples at 80°C for 15 min. DNA samples were placed on the surface of nitrocellulose membrane filter with 0.025-µm pore size floated on 50 mL nanopure H 2 O. After dialysis on float membranes for 45 min, the samples were extracted from the membrane and dried in a Savant SpeedVac DNA concentrator.
MALDI-TOF-MS Analysis
Both digested and undigested purified DNA samples were suspended in dH 2 0. One microliter of each DNA sample was mixed with 1 µL of 3-hydroxypicolinic acid saturated matrix (acetonitrile : dH 2 O : 100 mM ammonium citrate in a 1 : 1 : 2 ratio). Samples were then spotted on a MALDI stainless-steel sample plate and air dried before analysis by MS. Mass spectra were collected on a PE Voyager-DE-STR PerSeptive Biosystem MALDI-TOF MS with a 600-ns time delay. All MALDI-TOF MS spectra were calibrated to external standards including a 10-mer DNA oligomer.
